Charles River Laboratories Income Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 1,230.6 | 1,058.4 | 1,122.2 |
| Cost of Goods Sold | 752.4 | 651.8 | 693.5 |
| Gross Profit | 478.2 | 406.6 | 428.7 |
| Gross Profit Margin | 38.9% | 38.4% | 38.2% |
| SG&A Expense | 162.1 | 133.3 | 143.1 |
| Depreciation & Amortization | 88.9 | 85.1 | 104.6 |
| Operating Income | 227.2 | 188.2 | 181.0 |
| Operating Margin | 18.5% | 17.8% | 16.1% |
| Nonoperating Income | 8.2 | 7.8 | 3.8 |
| Nonoperating Expenses | 18.0 | 19.4 | 24.4 |
| Income Before Taxes | 217.4 | 176.6 | 160.4 |
| Income Taxes | 59.4 | 49.7 | 16.6 |
| Net Income After Taxes | 158.0 | 126.8 | 143.8 |
| Continuing Operations | 157.6 | 125.2 | 142.0 |
| Discontinued Operations | (3.2) | (181.0) | -- |
| Total Operations | 154.4 | (55.8) | 142.0 |
| Total Net Income | 154.4 | (55.8) | 142.0 |
| Net Profit Margin | 12.5% | -- | 12.7% |
| Diluted EPS from Total Net Income ($) | 2.25 | (0.80) | 1.96 |
| Dividends per Share | -- | -- | -- |





